entertainment -WSS

entertainment

author：explore 2025-09-14 09:59:08 - browse：3

Elf Bar disposable vape flavored vaping e-cigarette products are displayed in a convenience store. — The FDA is ramping up its efforts to force vape shops and other retailers to stop selling Elf Bar and Esco Bar products. PATRICK T. FALLON/AFP via Getty Images

WASHINGTON — The Food and Drug Administration is ramping up its efforts to force vape shops and other retailers to stop selling unauthorized disposable vape brands that are increasingly popular with young people.

The FDA recently issued 189 formal warning letters to shops selling two brands of vape products, Elf Bar and Esco Bars, the agency announced in a press release Thursday. The FDA has not authorized either brand, both of which are ubiquitous in gas stations and smoke shops around the country. They are therefore illegal to sell.

“This latest blitz should be a wake-up call for retailers of Elf Bar and Esco Bars products nationwide,” said Brian King, the head of the FDA’s tobacco center in a statement announcing the blitz.

Unlock this article by subscribing to STAT+ and enjoy your first 30 days free!

GET STARTED Log In

Previous article： Drug repurposing or repositioning? The language matters
Next article： STAT Summit: Meghan O’Rourke on making chronic illness visible

focus

WSS

STAT Readout Newsletter: Biotech news today

Study on Amgen’s bispecific immunotherapy produces positive data

Who gets to use the title 'doctor'?

Why police arrested suspected Gilgo Beach killer away from his house

Involuntary treatment for addiction doesn't work

Roche acquires Telavant from Roivant, adding experimental IBD treatment

entertainment

entertainment

entertainment

Hepatitis C has a cure — but many Americans still lack access to it

Who gets to use the title 'doctor'?

Hepatitis C has a cure — but many Americans still lack access to it

Health tech investors get more selective as pandemic boom fades

Heart attack and stroke risk calculators need revising

Why a market frenzy over new weight loss drugs defies logic

Trump demands the U.S. pay no more for drugs than other countries … again

J&J lung cancer data amount to new salvo against AstraZeneca

Hepatitis C has a cure — but many Americans still lack access to it

UnitedHealth, Optum discontinue NaviHealth name

knowledge

Study on Amgen’s bispecific immunotherapy produces positive data

Involuntary treatment for addiction doesn't work

Smaller biotechs seek to piggyback on weight loss drug boom

Roche drug slashes death risk in early

J&J lung cancer data amount to new salvo against AstraZeneca

Merck, Daiichi strike cancer drug pact worth up to $22 billion

hotspot

hotspot

focus

knowledge